Skip to content

BD BBL™ Mannitol Salt Agar 221271Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ Mannitol Salt Agar · Class 1

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10382902212710), received between Aug 8, 2022 and Aug 8, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 8, 2022Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ MANNITOL SALT AGAR THAT THE PRODUCT HAD THE WRONG PH RIGHT OUT OF THE BOX. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "CUSTOMER REPORTS MEDIA 221271 WITH LOT#:2125146 HAD THE WRONG PH RIGHT OUT OF THE BOX. PO#: (B)(6). MULTIPLE ATTEMPTS WERE MADE TO CONTACT THE CUSTOMER."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15188674 ↗

Other CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL devices

All CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page